Our company, based in Canada, has extensive experience in the development and production of high-quality human pharmaceuticals. Building upon this foundation, we have expanded into the veterinary field to address the growing need for advanced joint care solutions in equine medicine.
Dr.V is our specialized intra-articular joint injection for horses, designed with the same rigorous standards and commitment to safety that define our human medicines. By combining cutting-edge research with veterinary expertise, we deliver products that improve joint health, mobility, and overall performance of horses. Our mission is to provide veterinarians and horse owners with reliable, effective, and science-driven therapies that support animal welfare and enhance the quality of life for performance and companion horses alike
Active ingredient: Sodium Hyaluronate (Hyaluronate Sodium)
Concentration: 30 mg/mL
Strength: 60 mg / 2 mL
Volume: 2 mL per syringe
Packaging: Sterile pre-filled syringe, veterinary use only
For intra-articular use in horses only.
Indicated for the treatment of joint disorders associated with non-infectious synovitis and
osteoarthritis.
Recommended dose: 2 mL intra-articular injection.
Use only under veterinary supervision.
Repeat treatments may be given as required by the veterinarian.
– For veterinary use only.- Do not inject intravenously.- Not for use in animals intended for human consumption.- Strict aseptic technique must be observed.- In case of severe inflammatory response post-injection, infection should be suspected and
treated.
Possible mild and transient inflammatory joint reactions.
In rare cases, localized swelling or discomfort may occur.
Store at 2°C to 8°C (refrigerated).
Do not freeze.
Protect from excessive heat and light.
Hyaluronic acid is the prototype of a wide range of saccharide biopolymers (glycosaminoglycans or mucopolysaccharides) consisting of repeating disaccharide units of N-acetyl-D-glucosamine and D-glucuronic acid linked by beta 1-3 and beta 1-4 glycosidic bonds. A component of all mammalian connective tissue, hyaluronic acid confers viscoelastic and lubricating properties to synovial fluid1 and structural integrity to cartilage matrix2 . As a therapeutic agent, hyaluronic acid injected into arthritic joints has been shown, in a variety of animal model systems including horses3 , to improve joint function and to activate tissue repair processes in articular cartilage.